Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenoxy]propan-2-ol | - |
Capra hircus | |
2,5-diphenyl-1,3,4-oxadiazole | 1 mM, 50.19% activity remaining | Capra hircus | |
2-(2-chlorophenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 25.12% activity remaining | Capra hircus | |
2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 45.35% activity remaining | Capra hircus | |
2-(2-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 92.07% activity remaining | Capra hircus | |
2-(3-chlorophenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 36.19% activity remaining | Capra hircus | |
2-(3-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 48.08% activity remaining | Capra hircus | |
2-(3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 59.47% activity remaining | Capra hircus | |
2-(4-chlorophenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 30.98% activity remaining | Capra hircus | |
2-(4-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 43.49% activity remaining | Capra hircus | |
2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 49.89% activity remaining | Capra hircus | |
2-(4-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | 1 mM, 69.33% activity remaining | Capra hircus | |
2-benzyl-N'-methyl-N'-(pyridin-3-yl)but-3-ynehydrazide | - |
Capra hircus | |
2-[[(2E)-2-(1,3-benzodioxol-5-ylmethylidene)hydrazinyl]carbonyl]-3-phenyl-1H-indole-5-sulfonamide | - |
Capra hircus | |
4-bromo-N-[(2-methylimidazo[1,2-a]pyridin-3-yl)carbonyl]benzenecarbohydrazonoyl chloride | - |
Capra hircus | |
Leu-CH2Cl | - |
Capra hircus | |
additional information | 2,5-diaryloxadiazoles and their precursors as inhibitors of cathepsins B, H and L, synthesis and inhibitory potencies, pharmacological evaluation, molecular docking, overview. Structure-activity relationship studies show that 2,5-diaryloxadiazoles are less inhibitory than their precursors, N-subsituted benzylidenebenzohydrazides. Cathepsin H activity is maximally inhibited by (2E)-3-(3-methoxyphenyl)-1-phenylprop-2-en-1-one and (2Z)-2-[(2E)-3-(4-chlorophenyl)-1-phenylprop-2-en-1-ylidene]hydrazinecarboxamide, assay with liver hommogenate. All compounds exhibited a competitive type of inhibition | Capra hircus | |
N'-(4-[(E)-[2-(2-formylphenyl)hydrazinylidene]methyl]phenyl)-N-phenylimidoformamide | - |
Capra hircus | |
N-(3-methoxypyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide | - |
Capra hircus | |
N-benzyl-5-hydroxy-1-methyl-2-[2-[(1,3,4-oxadiazol-2-ylcarbonyl)amino]propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide | - |
Capra hircus | |
N-[(1E,2S)-1-(2-benzoylhydrazinylidene)-4-phenylbutan-2-yl]-N2-(piperidin-1-ylcarbonyl)-L-leucinamide | - |
Capra hircus | |
N-[(5S,8S,11S,13Z,19S)-8-(4-fluorobenzyl)-5-formyl-2,7,10-trioxo-18-oxa-1,6,9-triazabicyclo[17.2.1]docos-13-en-11-yl]-5-methyl-1,2-oxazole-3-carboxamide | - |
Capra hircus | |
N-[(E)-(phenylimino)methyl]benzamide | 1 mM, 69.90% activity remaining | Capra hircus | |
N-[(E)-[(2-chlorophenyl)imino]methyl]benzamide | 1 mM, 25.66% activity remaining | Capra hircus | |
N-[(E)-[(2-methoxyphenyl)imino]methyl]benzamide | 1 mM, 41.11% activity remaining | Capra hircus | |
N-[(E)-[(2-nitrophenyl)imino]methyl]benzamide | 1 mM, 90.07% activity remaining | Capra hircus | |
N-[(E)-[(3-chlorophenyl)imino]methyl]benzamide | 1 mM, 39.45% activity remaining | Capra hircus | |
N-[(E)-[(3-methoxyphenyl)imino]methyl]benzamide | 1 mM, 49.59% activity remaining | Capra hircus | |
N-[(E)-[(3-nitrophenyl)imino]methyl]benzamide | 1 mM, 73.01% activity remaining | Capra hircus | |
N-[(E)-[(4-chlorophenyl)imino]methyl]benzamide | 1 mM, 24.75% activity remaining | Capra hircus | |
N-[(E)-[(4-methoxyphenyl)imino]methyl]benzamide | 1 mM, 40.2% activity remaining | Capra hircus | |
N-[(E)-[(4-methylphenyl)imino]methyl]benzamide | 1 mM, 39.93% activity remaining | Capra hircus | |
N-[(E)-[(4-nitrophenyl)imino]methyl]benzamide | 1 mM, 75.07% activity remaining | Capra hircus | |
N-[2-(4-methoxyphenyl)ethyl]-2-(2-phenoxyphenyl)acetamide | - |
Capra hircus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
lysosome | - |
Capra hircus | 5764 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Capra hircus | A0A060INS8 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Capra hircus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Leu-2-naphthylamide + H2O | - |
Capra hircus | leucine + 2-naphthylamine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
CTSH | - |
Capra hircus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Capra hircus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
5 | - |
assay at | Capra hircus |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.00044 | - |
N-[(E)-[(4-chlorophenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00056 | - |
2-(2-chlorophenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00068 | - |
N-[(E)-[(2-chlorophenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.001 | - |
2-(4-chlorophenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00113 | - |
2-(3-chlorophenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00113 | - |
N-[(E)-[(3-chlorophenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00126 | - |
N-[(E)-[(4-methylphenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00133 | - |
2-(4-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00133 | - |
N-[(E)-[(4-methoxyphenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.0014 | - |
N-[(E)-[(2-methoxyphenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00147 | - |
2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00161 | - |
2-(3-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00168 | - |
N-[(E)-[(3-methoxyphenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00214 | - |
N-[(E)-(phenylimino)methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00255 | - |
2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00272 | - |
2,5-diphenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00364 | - |
N-[(E)-[(3-nitrophenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00385 | - |
2-(3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00416 | - |
N-[(E)-[(4-nitrophenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00484 | - |
N-[(E)-[(2-nitrophenyl)imino]methyl]benzamide | pH 5.0, 37°C | Capra hircus | |
0.00496 | - |
2-(4-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus | |
0.00669 | - |
2-(2-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | pH 5.0, 37°C | Capra hircus |